Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02040077 · ClinicalTrials.gov registry record · NA

Evaluation of a Computerized Opioid Overdose Prevention Program

A NA study of Treatment as Usual and Computer + Fluency, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT02040077: Completed NA study of Treatment as Usual and Computer + Fluency, sponsored by Johns Hopkins University.

NCT02040077 is a NA study of Treatment as Usual and Computer + Fluency that has completed, run by Johns Hopkins University. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02040077, a NA study of Treatment as Usual and Computer + Fluency, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Unintentional fatal drug overdose (OD) is now the 2nd leading cause of accidental death in the general population. Fatal OD from opioid analgesics specifically has increased over 400% between 1999 and 2008, and nonfatal overdose occurs at a rate 3-7 greater than fatal OD. Unintentional opioid OD is a public health crisis in several societal populations including drug users, patients being treated for chronic pain, elderly individuals, adolescents, and children. Educational interventions have been developed to increase knowledge regarding opioid OD risk factors, symptoms, and appropriate responses, however no randomized controlled evaluations of these interventions have been conducted. Within-subject evaluations report immediate and sustained increases in participant knowledge and behavior change, yet these programs suffer from limitations that may limit their widespread dissemination. Thus, there is an urgent, critical need to develop an opioid OD educational intervention that can be accessed by a broad audience, and produces immediate and sustained gains in knowledge in an easily administered and cost-effective way. This study will develop a web-based, computerized, interactive, opioid OD education training program that will incorporate multi-media learning components and fluency training to produce knowledge gains. This program will be evaluated using a randomized, controlled comparison of the active intervention against two control interventions. Participants will be recruited from a brief inpatient detoxification (n=75), will receive the intervention immediately upon completing the detoxification (post-treatment), and will complete 2 follow-up visits to evaluate sustained knowledge. The primary outcome will be percent change from baseline on a knowledge test that is administered immediately before and after the intervention, and at a 1 and 3-month follow-up visit. Secondary outcomes will include self-reported behavior change and participant acceptance of the int

Primary Outcome

The primary outcome is based on performance in the randomized, controlled trial and is change from baseline on a knowledge test that is administered immediately before and after the intervention. At the time of the study, no validated scales to assess general information regarding overdose in a true/false manner were available. Therefore the study developed a scale for the purpose of measuring knowledge increase. The scale included 51 items, rated as "true", "false", or "I don't know" (to disco

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Computer + Fluency
  • BEHAVIORAL Computer Only

Study Locations (1)

Maryland

  • Johns Hopkins University Bayview Medical Campus - Baltimore

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2015-01
Est. Completion 2015-09
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT02040077 record still lists

NCT02040077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Treatment as Usual appearing as the primary indexed condition, and to 3 interventions - of which Treatment as Usual is the first listed.

NCT02040077 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02040077 about?

NCT02040077 is a clinical study titled "Evaluation of a Computerized Opioid Overdose Prevention Program". Unintentional fatal drug overdose (OD) is now the 2nd leading cause of accidental death in the general population. Fatal OD from opioid analgesics specifically has increased over 400% between 1999 and 2008, and nonfatal overdose occurs at a rate 3-7 greater than fatal OD. Unintentional opioid OD is ...

What is the current status of trial NCT02040077?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2015-01. Estimated completion is 2015-09.

What conditions does trial NCT02040077 study?

This clinical trial studies the following conditions: Treatment as Usual, Computer + Fluency, Computer Only.

What interventions are being tested in trial NCT02040077?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Computer + Fluency (BEHAVIORAL), Computer Only (BEHAVIORAL).

Who is sponsoring clinical trial NCT02040077?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02040077 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Treatment as Usual

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02040077's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02040077, the US trial registry maintained by the National Library of Medicine. NCT02040077 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.